Danuglutide vs Dulaglutide
Molecule comparison
Last updated 2026-05-28 15:46 UTCDanuglutide is an experimental GLP-1 drug still in development, while dulaglutide (sold as Trulicity) is an FDA-approved GLP-1 treatment. Dulaglutide is approved for type 2 diabetes and reducing cardiovascular risk, whereas danuglutide has no approved uses yet. Both work the same way by acting as GLP-1 receptor agonists, but dulaglutide is already on the market as a once-weekly injection.
AI summary of the sources below.
| Danuglutide | Dulaglutide | |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | GLP-1 receptor agonist |
| Status | Pipeline | Approved |
| Branded products | — | trulicity |
Compare full details on the Danuglutide and Dulaglutide pages.